Janney Montgomery Scott LLC raised its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 43.9% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,713 shares of the company’s stock after acquiring an additional 1,132 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Henry Schein were worth $301,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also bought and sold shares of the business. Cambridge Investment Research Advisors Inc. raised its holdings in Henry Schein by 2.4% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 5,262 shares of the company’s stock valued at $459,000 after acquiring an additional 122 shares during the period. Contravisory Investment Management Inc. increased its holdings in shares of Henry Schein by 2.1% in the second quarter. Contravisory Investment Management Inc. now owns 6,895 shares of the company’s stock worth $559,000 after purchasing an additional 141 shares during the last quarter. Studio Investment Management LLC increased its holdings in shares of Henry Schein by 3.9% in the fourth quarter. Studio Investment Management LLC now owns 4,160 shares of the company’s stock worth $332,000 after purchasing an additional 155 shares during the last quarter. Kentucky Retirement Systems Insurance Trust Fund increased its holdings in shares of Henry Schein by 3.4% in the third quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 4,878 shares of the company’s stock worth $321,000 after purchasing an additional 161 shares during the last quarter. Finally, Wetherby Asset Management Inc. increased its holdings in shares of Henry Schein by 1.6% in the first quarter. Wetherby Asset Management Inc. now owns 10,860 shares of the company’s stock worth $947,000 after purchasing an additional 171 shares during the last quarter. 93.31% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several brokerages have recently issued reports on HSIC. Credit Suisse Group reaffirmed an “outperform” rating and issued a $96.00 target price on shares of Henry Schein in a report on Tuesday, August 8th. Stifel Nicolaus reduced their target price on Henry Schein from $80.00 to $70.00 and set a “hold” rating on the stock in a report on Wednesday. Piper Sandler reduced their target price on Henry Schein from $94.00 to $84.00 and set an “overweight” rating on the stock in a report on Thursday, October 26th. JPMorgan Chase & Co. lifted their price target on Henry Schein from $80.00 to $83.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 9th. Finally, Bank of America dropped their price target on Henry Schein from $76.00 to $75.00 in a research report on Monday, August 7th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, Henry Schein has a consensus rating of “Hold” and a consensus price target of $81.13.
Henry Schein Stock Down 3.4 %
Shares of NASDAQ:HSIC opened at $61.89 on Friday. Henry Schein, Inc. has a 1 year low of $60.01 and a 1 year high of $89.72. The business has a 50 day simple moving average of $72.53 and a two-hundred day simple moving average of $76.32. The firm has a market capitalization of $8.08 billion, a PE ratio of 18.20, a price-to-earnings-growth ratio of 1.81 and a beta of 0.83. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.72 and a quick ratio of 0.91.
Henry Schein (NASDAQ:HSIC – Get Free Report) last announced its earnings results on Monday, August 7th. The company reported $1.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.03. Henry Schein had a return on equity of 15.76% and a net margin of 3.64%. The business had revenue of $3.10 billion during the quarter, compared to analyst estimates of $3.13 billion. During the same quarter in the previous year, the business earned $1.16 earnings per share. The company’s revenue for the quarter was up 2.3% compared to the same quarter last year. On average, equities analysts predict that Henry Schein, Inc. will post 5.27 EPS for the current year.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
- Five stocks we like better than Henry Schein
- How Can Investors Benefit From After-Hours Trading
- A bullish storm is brewing for cloud stocks
- How to Analyze Restaurant Stocks
- Is Extreme Networks’ forecast a sign of industry woes?
- What is a Non-Fungible Token (NFT)? Definition and How it Works
- Profits come after ignorance Is highest: A PayPal story
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.